Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Treasury Shares: 2017-2025

Historic Treasury Shares for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $1.4 million.

  • Puma Biotechnology's Treasury Shares fell 0.47% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 0.47%. This contributed to the annual value of $1.3 million for FY2024, which is 20.65% down from last year.
  • Latest data reveals that Puma Biotechnology reported Treasury Shares of $1.4 million as of Q3 2025, which was down 25.07% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Treasury Shares ranged from a high of $2.5 million in Q1 2021 and a low of $1.3 million during Q4 2024.
  • For the 3-year period, Puma Biotechnology's Treasury Shares averaged around $1.8 million, with its median value being $1.8 million (2025).
  • As far as peak fluctuations go, Puma Biotechnology's Treasury Shares decreased by 24.53% in 2021, and later increased by 24.33% in 2023.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Treasury Shares stood at $1.4 million in 2021, then increased by 7.32% to $1.5 million in 2022, then climbed by 8.20% to $1.6 million in 2023, then decreased by 20.65% to $1.3 million in 2024, then dropped by 0.47% to $1.4 million in 2025.
  • Its Treasury Shares was $1.4 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q1 2025.